Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +3.30% | -5.53% | +16.05% |
Jun. 10 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
May. 16 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- TNYA Stock
- Revisions Tenaya Therapeutics, Inc.